APA (7th ed.) Citation

Hirose, Y., Shindo, N., Mori, M., Onitsuka, S., Isogai, H., Hamada, R., . . . Ojida, A. (2022). Discovery of Chlorofluoroacetamide-Based Covalent Inhibitors for Severe Acute Respiratory Syndrome Coronavirus 2 3CL Protease. Journal of medicinal chemistry, 65(20), 13852-13865. https://doi.org/10.1021/acs.jmedchem.2c01081

Chicago Style (17th ed.) Citation

Hirose, Yuya, et al. "Discovery of Chlorofluoroacetamide-Based Covalent Inhibitors for Severe Acute Respiratory Syndrome Coronavirus 2 3CL Protease." Journal of Medicinal Chemistry 65, no. 20 (2022): 13852-13865. https://doi.org/10.1021/acs.jmedchem.2c01081.

MLA (9th ed.) Citation

Hirose, Yuya, et al. "Discovery of Chlorofluoroacetamide-Based Covalent Inhibitors for Severe Acute Respiratory Syndrome Coronavirus 2 3CL Protease." Journal of Medicinal Chemistry, vol. 65, no. 20, 2022, pp. 13852-13865, https://doi.org/10.1021/acs.jmedchem.2c01081.